Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$643K Buy
9,272
+4,542
+96% +$343K ﹤0.01% 922
2023
Q2
$400K Buy
+4,730
New +$387K 0.01% 844
2023
Q1
Sell
-6,615
Closed -$495K 1351
2022
Q4
$495K Buy
6,615
+648
+11% +$46.1K ﹤0.01% 1106
2022
Q3
$386K Buy
+5,967
New +$413K ﹤0.01% 1167
2021
Q1
Sell
-233
Closed -$17K 957
2020
Q4
$17K Buy
+233
New +$16.4K ﹤0.01% 739
2017
Q2
Sell
-24
Closed -$1K 499
2017
Q1
$1K Buy
+24
New +$978 ﹤0.01% 472

Other funds holding HOLX

Pathstone Family Office's HOLX Position: Q3 2023 in Review

Pathstone Family Office increased its Hologic (HOLX) stake by 96% in Q3 2023, buying an estimated $343K and bringing the position to 9,272 shares worth $643K. The position accounts for ﹤0.01% of the portfolio, ranked #922.

Pathstone Family Office first reported a position in HOLX in Q1 2017 and has held it in 6 quarters since. 693 funds tracked by Wall St. Rank hold HOLX as of Q3 2023.

  • Pathstone Family Office held 9,272 shares of Hologic worth $643K as of Q3 2023.
  • Pathstone Family Office bought 4,542 Hologic shares in Q3 2023, an estimated $343K.
  • Hologic made up ﹤0.01% of Pathstone Family Office's portfolio in Q3 2023, its #922 holding.
  • Pathstone Family Office first reported a position in Hologic in Q1 2017 and has held it in 6 quarters since.
  • 693 funds tracked by Wall St. Rank held Hologic as of Q3 2023.

Based on Pathstone Family Office's 13F filing for Q3 2023, filed 8 Nov 2023.